Expert Panel: Access to Evidence-based Therapies Is Necessary to Support Individualized Treatment of HIV

June 28, 2019

This opinion paper, developed by a multidisciplinary panel of HIV experts in 2019 reflects the group’s consensus on recommendations for various stakeholders who work to improve HIV care, including population health decision-makers (such as formulary committees, pharmacy benefit managers, and clinical advisors), advocacy organizations, and local, state, and federal policy makers.

This opinion paper, developed by a multidisciplinary panel of HIV experts in 2019 reflects the group’s consensus on recommendations for various stakeholders who work to improve HIV care, including population health decision-makers (such as formulary committees, pharmacy benefit managers, and clinical advisors), advocacy organizations, and local, state, and federal policy makers.